Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively.
about
The use of laboratory tests in the diagnosis of SLERisk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.Systemic lupus erythematosus VII: frequency and impact of secondary Sjøgren's syndrome.Outcome and survival in systemic lupus erythematosusArthritis and epidemiology in Europe.Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.Childhood- and adult-onset lupus: an update of similarities and differences.End-stage renal disease in lupus: disease activity, dialysis, and the outcome of transplantation.A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review.Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
P2860
Q24682977-0713DBAC-AA9D-450F-88C3-2BF1EF83DFF5Q33341018-F3BE7702-CAF9-4E8C-853C-67438C46A1D1Q33387223-C3E65411-7B6F-4479-A746-DE0B7800E197Q33491307-A96FB47B-4B02-4508-A194-A9433524C0A9Q33502888-C849FC93-194D-4579-8210-11CDAB932455Q33561735-969D692E-0A58-498B-931E-DE024C133B3BQ33562414-E0D61545-76A5-43FB-9636-E103C70BEAC2Q37640271-998EDBDE-70D0-44C2-9CB6-442D482AE981Q37754678-0DCE8AE1-2554-446B-ADAC-FD0D00E3329AQ40829252-A8E0CB55-17FE-451F-AC45-F799018249DEQ41926859-ECC7693C-E131-44D8-A971-2E6BF410B601Q42634173-9EC83D42-6F4C-4311-A602-A2E6626373FCQ44089331-B892FD87-283E-4CB8-B7C0-1939DFA710AFQ44911567-4B756A61-358A-4334-92BD-727BF3DF9F6F
P2860
Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Systemic lupus erythematosus. ...... atients studied prospectively.
@ast
Systemic lupus erythematosus. ...... atients studied prospectively.
@en
Systemic lupus erythematosus. ...... atients studied prospectively.
@nl
type
label
Systemic lupus erythematosus. ...... atients studied prospectively.
@ast
Systemic lupus erythematosus. ...... atients studied prospectively.
@en
Systemic lupus erythematosus. ...... atients studied prospectively.
@nl
prefLabel
Systemic lupus erythematosus. ...... atients studied prospectively.
@ast
Systemic lupus erythematosus. ...... atients studied prospectively.
@en
Systemic lupus erythematosus. ...... atients studied prospectively.
@nl
P2093
P2860
P356
P1476
Systemic lupus erythematosus. ...... atients studied prospectively.
@en
P2093
Bronsveld W
Nieuwenhuys EJ
Nossent JC
van Rooyen A
P2860
P304
P356
10.1136/ARD.48.6.455
P407
P577
1989-06-01T00:00:00Z